Earnings Feed
Start Free
Home/Filings/3/A/0000899243-21-021705
3/A//SEC Filing

INDEX VENTURES LIFE VI (JERSEY) L.P. 3/A

Accession 0000899243-21-021705

CIK 0001847903other
View on SEC.govCompany Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 10:12 AM ET

Size

10.6 KB

Accession

0000899243-21-021705

Insider Transaction Report

Form 3/AAmended
Period: 2021-05-27
Centessa Pharmaceuticals plcCNTA
INDEX VENTURES LIFE VI (JERSEY) L.P.
10% Owner
Holdings

  • Ordinary Shares

    149,421

  • Ordinary Shares

    9,812,368
Yucca (Jersey) SLP
10% Owner
Holdings

  • Ordinary Shares

    149,421

  • Ordinary Shares

    9,812,368
Index Venture Life Associates VI Ltd
10% Owner
Holdings

  • Ordinary Shares

    9,812,368

  • Ordinary Shares

    149,421
Footnotes (4)
  • [F1]Represents A Ordinary Shares that will be redesignated as Ordinary Shares immediately prior to the closing of the initial public offering ("IPO").
  • [F2]Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F3]Held by Index Ventures Life VI (Jersey) LP, a Jersey limited partnership ("Index Ventures Life VI"). Index Venture Life Associates VI Limited, a Jersey limited liability company ("Index Venture Life VI GP"), is the managing general partner of Index Ventures Life VI. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Index Ventures Life VI, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they have beneficial ownership of such shares for Section 16 or any other purpose.
  • [F4]Held by Yucca (Jersey) SLP, a Jersey separate limited partnership ("Yucca"). Yucca administers the Index Ventures Life VI co-investment vehicle that is contractually required to mirror the investment in the shares by Index Ventures Life VI. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Yucca, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they have beneficial ownership of such shares for Section 16 or any other purpose.

Documents

1 file

Issuer

Centessa Pharmaceuticals plc

CIK 0001847903

→
Entity typeother
IncorporatedJersey

Related Parties

1
  • filerCIK 0001591199

Filing Metadata

Form type
3/A
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 10:12 AM ET
Size
10.6 KB
View on SEC.gov